Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Part D
Fierce Healthcare
HRSA taps Pfizer, AbbVie, others for revised 340B rebate pilot
The list of approved participants and drugs is larger than the controversial pilot's first attempted launch.
Dave Muoio
Oct 2, 2026 1:00pm
Brand-name drug prices climb with age in US, fall abroad: report
May 29, 2026 8:10am
Fierce Healthcare
CMS delays Part D GLP-1 model amid skepticism from insurers
Apr 22, 2026 12:00pm
Fierce Healthcare
CMMI proposes new models to lower drug prices in Parts B, D
Dec 22, 2025 12:00pm
Teva's subdued outlook puts damper on strong 2024 results
Jan 29, 2025 1:13pm
Congress has 'time-limited' chance to fix high drug costs
Jul 14, 2021 10:40am